Gene therapy of Duchenne muscular dystrophy using own stem cells and human artificial chromosome

点击翻译按钮获取中文摘要

Toward gene therapy of Duchenne muscular dystrophy(DMD), we transferred the human artificial chromosome with 2. 4 Mb genomic dystrophin gene(DYS-HAC) to the DMD mouse model(mdx)-derived mesoangioblasts, then the corrected mesoangioblasts were transplanted to mdx-mice. As a result, we succeeded in the long term-amelioration of the dystrophic phenotype in the mdx mice. Thus, a combination of HAC-mediated gene replacement and transplantation with mesoangioblasts will be useful for gene therapy of DMD.